In the year after July 2002, when it was announced that estrogen-progestin hormone pills posed an increased risk of breast cancer, heart disease and other illnesses in post-menopausal women, the number of prescriptions for hormone supplements plunged by more than one-third, according to a study published in the Journal of the American Medical Association. The study estimated 2003 prescriptions for hormone treatments would total 57 million, compared with 91 million in 2001, before the risk study was published.

Full Story:

Related Summaries